UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Antimicrobial Peptides: An Update on Classifications and Databases

International journal of molecular sciences, 2021-10, Vol.22 (21), p.11691

2021

Volltextzugriff (PDF)

A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections

International journal of antimicrobial agents, 2020-01, Vol.55 (1), p.105833-105833, Article 105833

2020

Volltextzugriff (PDF)

Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?

International journal of antimicrobial agents, 2016-12, Vol.48 (6), p.592-597

2016

Volltextzugriff (PDF)

PK/PD models in antibacterial development

Current opinion in microbiology, 2013-10, Vol.16 (5), p.573-579

2013

Volltextzugriff (PDF)

Polymyxin causes cell envelope remodelling and stress responses in mcr-1-harbouring Escherichia coli

International journal of antimicrobial agents, 2022-02, Vol.59 (2), p.106505-106505, Article 106505

2022

Volltextzugriff (PDF)

Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and Enterobacterales

Antimicrobial agents and chemotherapy, 2022-02, Vol.66 (2), p.e0144621-e0144621

2022

Volltextzugriff (PDF)

A polytherapy based approach to combat antimicrobial resistance using cubosomes

Nature communications, 2022-01, Vol.13 (1), p.343-343, Article 343

2022

Volltextzugriff (PDF)

‘Old’ antibiotics for emerging multidrug-resistant bacteria

Current opinion in infectious diseases, 2012-12, Vol.25 (6), p.626-633

2012

Volltextzugriff (PDF)

Evaluation of intravenous to oral antimicrobial switch at a hospital with a tightly regulated antimicrobial stewardship program

British journal of clinical pharmacology, 2021-08, Vol.87 (8), p.3354-3358

2021

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of peptide antibiotics

Advanced drug delivery reviews, 2022-04, Vol.183, p.114171-114171, Article 114171

2022

Volltextzugriff (PDF)

Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3738-3745

2013

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?

Diagnostic microbiology and infectious disease, 2012-11, Vol.74 (3), p.213-223

2012

Volltextzugriff (PDF)

Overexpression of mcr-1 disrupts cell envelope synthesis and causes the dysregulation of carbon metabolism, redox balance and nucleic acids

International journal of antimicrobial agents, 2022-09, Vol.60 (3), p.106643-106643, Article 106643

2022

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3783-3789

2010

Volltextzugriff (PDF)

Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2006-06, Vol.50 (6), p.1953-1958

2006

Volltextzugriff (PDF)

Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens

Frontiers in microbiology, 2018-04, Vol.9, p.721-721

2018

Volltextzugriff (PDF)

In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2015-11, Vol.70 (11), p.3042-3050

2015

Volltextzugriff (PDF)

Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii

International journal of antimicrobial agents, 2021-02, Vol.57 (2), p.106271, Article 106271

2021

Volltextzugriff (PDF)

Dosing of colistin—back to basic PK/PD

Current opinion in pharmacology, 2011-10, Vol.11 (5), p.464-469

2011

Volltextzugriff (PDF)

Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5685-5695

2011

Volltextzugriff (PDF)

Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5134-5142

2011

Volltextzugriff (PDF)

Distinguishing inducible and non-inducible resistance to colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology modeling at low and standard inocula

Journal of pharmaceutical sciences, 2024-01, Vol.113 (1), p.202-213

2024

Volltextzugriff (PDF)

Arginine catabolism is essential to polymyxin dependence in Acinetobacter baumannii

Cell reports (Cambridge), 2024-07, Vol.43 (7), p.114410, Article 114410

2024

Volltextzugriff (PDF)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae

Frontiers in pharmacology, 2022-12, Vol.13, p.975066-975066

2022

Volltextzugriff (PDF)

Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae

Antimicrobial agents and chemotherapy, 2020-07, Vol.64 (8)

2020

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(71)
Pharmacology & Pharmacy
(50)
Humans
(38)
Microbiology
(37)
Anti-Bacterial Agents - Pharmacology
(29)
Infectious Diseases
(28)
Microbial Sensitivity Tests
(23)
Pharmacology
(18)
Pseudomonas Aeruginosa
(18)
Pharmacokinetics
(15)
Colistin
(14)
Colistin - Pharmacology
(14)
Antibiotics
(13)
Drug Synergism
(13)
Pseudomonas Aeruginosa - Drug Effects
(13)
Anti-Bacterial Agents - Pharmacokinetics
(12)
Pharmacodynamics
(12)
Polymyxin B - Pharmacology
(12)
Drug Resistance, Multiple, Bacterial
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Antimicrobial Peptides: An Update on Classifications and Databases

A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections

Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?

PK/PD models in antibacterial development

Polymyxin causes cell envelope remodelling and stress responses in mcr-1-harbouring Escherichia coli

Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and Enterobacterales

A polytherapy based approach to combat antimicrobial resistance using cubosomes

‘Old’ antibiotics for emerging multidrug-resistant bacteria

Evaluation of intravenous to oral antimicrobial switch at a hospital with a tightly regulated antimicrobial stewardship program

Pharmacokinetics and pharmacodynamics of peptide antibiotics

Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?

Overexpression of mcr-1 disrupts cell envelope synthesis and causes the dysregulation of carbon metabolism, redox balance and nucleic acids

Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model

Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa

Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens

In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa

Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii

Dosing of colistin—back to basic PK/PD

Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

Distinguishing inducible and non-inducible resistance to colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology modeling at low and standard inocula

Arginine catabolism is essential to polymyxin dependence in Acinetobacter baumannii

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae

Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae

Suchergebnisse filtern